Global Recombinant Human Thrombin Protein 麻豆原创 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR082412755

Publication Date:

August 21, 2024

Pages:

108

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Recombinant human thrombin protein is a laboratory-produced form of the human thrombin enzyme, which plays a crucial role in blood clotting. This recombinant version is created through genetic engineering techniques, often using bacteria or yeast to produce the protein. It's used in medical settings for various purposes, such as controlling bleeding during surgery or as a diagnostic tool.
The global Recombinant Human Thrombin Protein market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Recombinant Human Thrombin Protein market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Recombinant Human Thrombin Protein market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Recombinant Human Thrombin Protein market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Recombinant Human Thrombin Protein market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Recombinant Human Thrombin Protein market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Human Thrombin Protein
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Human Thrombin Protein market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies, Pfizer, Octapharma, Omrix Biopharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Recombinant Human Thrombin Protein market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Based Bovine
Based Human
Others
麻豆原创 segment by Application
Hospitals
Clinics
Academic and Research Institute
Major players covered
Takeda
Bayer
CSL
Grifols
GE Healthcare
Hualan Biological
Haematologic Technologies
Pfizer
Octapharma
Omrix Biopharmaceuticals
Shanghai RAAS
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Human Thrombin Protein product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Human Thrombin Protein, with price, sales quantity, revenue, and global market share of Recombinant Human Thrombin Protein from 2019 to 2024.
Chapter 3, the Recombinant Human Thrombin Protein competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Human Thrombin Protein breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Recombinant Human Thrombin Protein market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Human Thrombin Protein.
Chapter 14 and 15, to describe Recombinant Human Thrombin Protein sales channel, distributors, customers, research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Recombinant Human Thrombin Protein Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Based Bovine
1.3.3 Based Human
1.3.4 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Recombinant Human Thrombin Protein Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Academic and Research Institute
1.5 Global Recombinant Human Thrombin Protein 麻豆原创 Size & Forecast
1.5.1 Global Recombinant Human Thrombin Protein Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Recombinant Human Thrombin Protein Sales Quantity (2019-2030)
1.5.3 Global Recombinant Human Thrombin Protein Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Recombinant Human Thrombin Protein Product and Services
2.1.4 Takeda Recombinant Human Thrombin Protein Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Takeda Recent Developments/Updates
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Recombinant Human Thrombin Protein Product and Services
2.2.4 Bayer Recombinant Human Thrombin Protein Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Bayer Recent Developments/Updates
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Recombinant Human Thrombin Protein Product and Services
2.3.4 CSL Recombinant Human Thrombin Protein Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 CSL Recent Developments/Updates
2.4 Grifols
2.4.1 Grifols Details
2.4.2 Grifols Major Business
2.4.3 Grifols Recombinant Human Thrombin Protein Product and Services
2.4.4 Grifols Recombinant Human Thrombin Protein Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Grifols Recent Developments/Updates
2.5 GE Healthcare
2.5.1 GE Healthcare Details
2.5.2 GE Healthcare Major Business
2.5.3 GE Healthcare Recombinant Human Thrombin Protein Product and Services
2.5.4 GE Healthcare Recombinant Human Thrombin Protein Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 GE Healthcare Recent Developments/Updates
2.6 Hualan Biological
2.6.1 Hualan Biological Details
2.6.2 Hualan Biological Major Business
2.6.3 Hualan Biological Recombinant Human Thrombin Protein Product and Services
2.6.4 Hualan Biological Recombinant Human Thrombin Protein Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Hualan Biological Recent Developments/Updates
2.7 Haematologic Technologies
2.7.1 Haematologic Technologies Details
2.7.2 Haematologic Technologies Major Business
2.7.3 Haematologic Technologies Recombinant Human Thrombin Protein Product and Services
2.7.4 Haematologic Technologies Recombinant Human Thrombin Protein Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Haematologic Technologies Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Recombinant Human Thrombin Protein Product and Services
2.8.4 Pfizer Recombinant Human Thrombin Protein Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Pfizer Recent Developments/Updates
2.9 Octapharma
2.9.1 Octapharma Details
2.9.2 Octapharma Major Business
2.9.3 Octapharma Recombinant Human Thrombin Protein Product and Services
2.9.4 Octapharma Recombinant Human Thrombin Protein Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Octapharma Recent Developments/Updates
2.10 Omrix Biopharmaceuticals
2.10.1 Omrix Biopharmaceuticals Details
2.10.2 Omrix Biopharmaceuticals Major Business
2.10.3 Omrix Biopharmaceuticals Recombinant Human Thrombin Protein Product and Services
2.10.4 Omrix Biopharmaceuticals Recombinant Human Thrombin Protein Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Omrix Biopharmaceuticals Recent Developments/Updates
2.11 Shanghai RAAS
2.11.1 Shanghai RAAS Details
2.11.2 Shanghai RAAS Major Business
2.11.3 Shanghai RAAS Recombinant Human Thrombin Protein Product and Services
2.11.4 Shanghai RAAS Recombinant Human Thrombin Protein Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Shanghai RAAS Recent Developments/Updates
3 Competitive Environment: Recombinant Human Thrombin Protein by Manufacturer
3.1 Global Recombinant Human Thrombin Protein Sales Quantity by Manufacturer (2019-2024)
3.2 Global Recombinant Human Thrombin Protein Revenue by Manufacturer (2019-2024)
3.3 Global Recombinant Human Thrombin Protein Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Recombinant Human Thrombin Protein by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Recombinant Human Thrombin Protein Manufacturer 麻豆原创 Share in 2023
3.4.3 Top 6 Recombinant Human Thrombin Protein Manufacturer 麻豆原创 Share in 2023
3.5 Recombinant Human Thrombin Protein 麻豆原创: Overall Company Footprint Analysis
3.5.1 Recombinant Human Thrombin Protein 麻豆原创: Region Footprint
3.5.2 Recombinant Human Thrombin Protein 麻豆原创: Company Product Type Footprint
3.5.3 Recombinant Human Thrombin Protein 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Recombinant Human Thrombin Protein 麻豆原创 Size by Region
4.1.1 Global Recombinant Human Thrombin Protein Sales Quantity by Region (2019-2030)
4.1.2 Global Recombinant Human Thrombin Protein Consumption Value by Region (2019-2030)
4.1.3 Global Recombinant Human Thrombin Protein Average Price by Region (2019-2030)
4.2 North America Recombinant Human Thrombin Protein Consumption Value (2019-2030)
4.3 Europe Recombinant Human Thrombin Protein Consumption Value (2019-2030)
4.4 Asia-Pacific Recombinant Human Thrombin Protein Consumption Value (2019-2030)
4.5 South America Recombinant Human Thrombin Protein Consumption Value (2019-2030)
4.6 Middle East & Africa Recombinant Human Thrombin Protein Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Recombinant Human Thrombin Protein Sales Quantity by Type (2019-2030)
5.2 Global Recombinant Human Thrombin Protein Consumption Value by Type (2019-2030)
5.3 Global Recombinant Human Thrombin Protein Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Recombinant Human Thrombin Protein Sales Quantity by Application (2019-2030)
6.2 Global Recombinant Human Thrombin Protein Consumption Value by Application (2019-2030)
6.3 Global Recombinant Human Thrombin Protein Average Price by Application (2019-2030)
7 North America
7.1 North America Recombinant Human Thrombin Protein Sales Quantity by Type (2019-2030)
7.2 North America Recombinant Human Thrombin Protein Sales Quantity by Application (2019-2030)
7.3 North America Recombinant Human Thrombin Protein 麻豆原创 Size by Country
7.3.1 North America Recombinant Human Thrombin Protein Sales Quantity by Country (2019-2030)
7.3.2 North America Recombinant Human Thrombin Protein Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Recombinant Human Thrombin Protein Sales Quantity by Type (2019-2030)
8.2 Europe Recombinant Human Thrombin Protein Sales Quantity by Application (2019-2030)
8.3 Europe Recombinant Human Thrombin Protein 麻豆原创 Size by Country
8.3.1 Europe Recombinant Human Thrombin Protein Sales Quantity by Country (2019-2030)
8.3.2 Europe Recombinant Human Thrombin Protein Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Recombinant Human Thrombin Protein Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Recombinant Human Thrombin Protein Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Recombinant Human Thrombin Protein 麻豆原创 Size by Region
9.3.1 Asia-Pacific Recombinant Human Thrombin Protein Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Recombinant Human Thrombin Protein Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 South Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Recombinant Human Thrombin Protein Sales Quantity by Type (2019-2030)
10.2 South America Recombinant Human Thrombin Protein Sales Quantity by Application (2019-2030)
10.3 South America Recombinant Human Thrombin Protein 麻豆原创 Size by Country
10.3.1 South America Recombinant Human Thrombin Protein Sales Quantity by Country (2019-2030)
10.3.2 South America Recombinant Human Thrombin Protein Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Recombinant Human Thrombin Protein Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Recombinant Human Thrombin Protein Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Recombinant Human Thrombin Protein 麻豆原创 Size by Country
11.3.1 Middle East & Africa Recombinant Human Thrombin Protein Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Recombinant Human Thrombin Protein Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Recombinant Human Thrombin Protein 麻豆原创 Drivers
12.2 Recombinant Human Thrombin Protein 麻豆原创 Restraints
12.3 Recombinant Human Thrombin Protein Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Recombinant Human Thrombin Protein and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombinant Human Thrombin Protein
13.3 Recombinant Human Thrombin Protein Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Recombinant Human Thrombin Protein Typical Distributors
14.3 Recombinant Human Thrombin Protein Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Companies Mentioned:

Takeda
Bayer
CSL
Grifols
GE Healthcare
Hualan Biological
Haematologic Technologies
Pfizer
Octapharma
Omrix Biopharmaceuticals
Shanghai RAAS

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.